YARROW BIOSCIENCE, INC. Debt Securities, Available-for-sale, Amortized Cost
YARROW BIOSCIENCE, INC. (YARW) had Debt Securities, Available-for-sale, Amortized Cost of $297.00 thousand as of 2026-03-31, per its S-4/A filed 2026-06-03.
Financial Statements › Notes › Credit Losses
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2026-08-13
- 2026-03-31: Debt Securities, Available-for-sale, Amortized Cost $297.00K.
- 2025-12-31: Debt Securities, Available-for-sale, Amortized Cost $4.98M.
- 2025-06-30: Debt Securities, Available-for-sale, Amortized Cost $17.60M.
- 2025-03-31: Debt Securities, Available-for-sale, Amortized Cost $22.06M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost | Debt Securities, Available-for-sale, Amortized Cost as first filed |
|---|---|---|
| 2026-03-31 | $297.00K S-4/A · filed 2026-06-03 | |
| 2025-12-31 | $4.98M 10-Q · filed 2026-08-13 | |
| 2025-06-30 | $17.60M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $22.06M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $41.57M S-4/A · filed 2026-06-03 | |
| 2024-09-30 | $53.88M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $48.55M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $66.95M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $62.61M 10-K · filed 2025-03-06 | |
| 2020-09-30 | $2.02M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $2.02M 10-Q · filed 2020-08-06 | |
| 2019-12-31 | $15.66M 10-K · filed 2021-03-04 | $74.49M 10-K · filed 2020-03-03 |
| 2019-09-30 | $93.33M 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $109.41M 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $121.53M 10-Q · filed 2019-05-02 | |
| 2018-12-31 | $134.66M 10-K · filed 2020-03-03 | $136.35M 10-Q · filed 2019-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |